Name | Ethyl 2-(4-chloropyrimidin-5-yl)acetate |
---|---|
Synonyms | ethyl 2-(4-chloropyrimidin-5-yl)acetate |
Density | 1.277g/cm3 |
---|---|
Boiling Point | 289.286ºC at 760 mmHg |
Molecular Formula | C8H9ClN2O2 |
Molecular Weight | 200.62200 |
Flash Point | 128.756ºC |
Exact Mass | 200.03500 |
PSA | 52.08000 |
LogP | 1.23560 |
Index of Refraction | 1.522 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933599090 |
~93% 6214-47-7 |
Literature: CANCER THERAPEUTICS CRC PTY LTD; DEVLIN, Mark Graeme; STREET, Ian Philip; TONG, Warwick Bonner Patent: WO2014/27199 A1, 2014 ; Location in patent: Page/Page column 134 ; |
~% 6214-47-7 |
Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
~% 6214-47-7 |
Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
~% 6214-47-7 |
Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
Precursor 4 | |
---|---|
DownStream 0 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |